ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      18,902.40
      -0.20%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      72.43
      -1.21%
      Bitcoin
      60,341.99
      0.07%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Genaissance Pharmaceuticals (MM) (GNSC) Quote

      Genaissance Pharmaceuticals (MM)

      Genaissance Pharmaceuticals (MM) (GNSC)

      NASDAQ
      0.00
      0.00
      (0.00%)
      At close: September 18 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      -
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      -
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      GNSC Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      7 hours ago

      Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo

      NEW HAVEN, Conn. and TOKYO, Oct. 3 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into an agreement with Sankyo, Co., Ltd...

      October 03 2005
      PR Newswire (US)

      Genaissance Enters Pharmacogenomic Collaboration with Otsuka

      NEW HAVEN, Conn. and TOKYO, Sept. 21 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into a pharmacogenomic research collaboration...

      September 21 2005
      PR Newswire (US)

      Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements

      NEW HAVEN, Conn., and MARSEILLE, France, Sept. 12 /PRNewswire-FirstCall/ -- Privately-held Ipsogen SAS and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that they have signed...

      September 12 2005
      PR Newswire (US)

      Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract

      - Increases Presence in EU Ag Genotyping Market - NEW HAVEN, Conn., Aug. 23 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that it will provide its...

      August 23 2005
      PR Newswire (US)

      Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract

      - Will Address EU Mandate for Sheep-Breeding Programs That Confer Resistance to Scrapie - NEW HAVEN, Conn., Aug. 11 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC...

      August 11 2005
      PR Newswire (US)

      Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon

      Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon NEW HAVEN, Conn. and OSS, Netherlands, July 18 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals...

      July 18 2005
      PR Newswire (US)

      Clinical Data to Acquire Genaissance Pharmaceuticals

      Clinical Data to Acquire Genaissance Pharmaceuticals Combined Company to Deliver Industry-Defining Theranostics NEWTON, Mass., and NEW HAVEN, Conn., June 21 /PRNewswire-FirstCall/ -- Clinical...

      June 21 2005
      PR Newswire (US)

      Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics

      Clinical Data, Inc. (NASDAQ:CLDA) and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that they have signed an agreement for Clinical Data to acquire Genaissance Pharmaceuticals in...

      June 21 2005
      Business Wire

      Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner

      Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner NEW HAVEN, Conn., June 7 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced...

      June 07 2005
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      XCURExicure Inc
      $ 6.0395
      (163.73%)
      		6.55M
      VEROVenus Concept Inc
      $ 1.07
      (112.94%)
      		7.73M
      ZEOZeo Energy Corporation
      $ 1.70
      (49.12%)
      		87.41k
      TBIOTelesis Bio Inc
      $ 1.74
      (27.94%)
      		689.71k
      RELIReliance Global Group Inc
      $ 3.07
      (18.08%)
      		74.59k
      SMFLSmart for Life Inc
      $ 0.5093
      (-34.71%)
      		1.63M
      PGNYProgyny Inc
      $ 18.28
      (-25.20%)
      		75.11k
      CRMTAmericas Car Mart Inc
      $ 44.00
      (-11.93%)
      		5.81k
      OMEXOdyssey Marine Exploration Inc
      $ 1.25
      (-10.71%)
      		3.88M
      RNAZTransCode Therapeutics Inc
      $ 0.3156
      (-9.83%)
      		179.55k
      VEROVenus Concept Inc
      $ 1.07
      (112.94%)
      		7.73M
      XCURExicure Inc
      $ 6.0395
      (163.73%)
      		6.55M
      NVDANVIDIA Corporation
      $ 113.44
      (0.06%)
      		5.26M
      OMEXOdyssey Marine Exploration Inc
      $ 1.25
      (-10.71%)
      		3.85M
      EJHE Home Household Service Holdings Ltd
      $ 0.105
      (-0.94%)
      		3.61M

      GNSC Discussion

      View Posts
      DougS. DougS. 20 years ago
      Thanks. I don't own any. Just curious about the company. I've been waiting for them to take the next step to legitimize their science but it hasn't been forthcoming. Still waiting.

      FYI - a prospectus came out that shows deteriorating financials. So be careful! Good luck.

      http://www.shareholder.com/GNSC/EdgarDetail.cfm?CompanyID=GNSC&CIK=1110009&FID=1047469-05-15...
      👍️0
      gator16 gator16 20 years ago
      I own a lot of GNSC..maybe too much..I keep hearing great things are coming though....guess I will have to wait a while !
      98000 shrs at $3.26 groan !!
      👍️0
      DougS. DougS. 20 years ago
      Anyone out there follow this company besides me???

      👍️0
      gator16 gator16 20 years ago
      Welcome everyone to this new board. This company is the future !!
      👍️0

      Your Recent History

      NASDAQ
      GNSC
      Genaissance
      Delayed Upgrade Clock